Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

And that blow arrived just two days later when global pharmaceutical giants AstraZeneca (AZ) suddenly revealed they were ...

Earnings per share excluding some items surged to $2.09, Astra said Thursday, higher than the $2.04 estimated by analysts ...

US stocks traded lower after fresh data showed the economy added 143,000 jobs in January, fewer than the 175,000 expected by ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

Q4 2024 Earnings Call Transcript February 6, 2025 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.05 EPS, ...

As part of his love-in with infrastructure, the Prime Minister is vowing to 'rip up the rules' and grant planning licences ...

How an agreement set up by the Tories and lauded by Labour fell victim to cost-cutting and UK curbs on drugs expenditure ...

THE Bank of England yesterday lowered interest rates from 4.75 per cent to 4.5, while halving its growth forecasts amid fears ...

In addition to the UK investment controversy, AstraZeneca is also dealing with legal challenges in China. The company ...

Q4 2024 Earnings Call Feb 06, 2025, 6:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants ...

Growing at a rate of knots from the Cambridge Biomedical Campus, AstraZeneca hoisted its market cap to £183.58 billion and ...